Prologue Medicines names Stephen Harrison chief scientific officer

Oct 13, 2026
Stephen Harrison will direct Prologue Medicines' scientific strategy and the development of its DELVE machine learning platform and drug pipeline.

Prologue Medicines appointed Stephen Harrison as chief scientific officer on October 13, the company announced in a press release. Harrison will direct its scientific and research strategy, including work on the DELVE machine learning platform and its pipeline of medicines derived from viral proteins.

Harrison previously served as chief scientific officer at Nucleome Therapeutics and held leadership roles at Engine Biosciences, Relypsa and KAI Pharmaceuticals. His work included contributions to the approved medicines Veltassa and Parsabiv.

Prologue also appointed Jason Silvers and Adrian Rawcliffe to its board of directors. Silvers is president and chief financial officer of Generate Biomedicines, while Rawcliffe is a CEO Partner at Flagship Pioneering and chief executive of Etiome.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.